Innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements
US5482945A · kind A · utility
42Cited by
6References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 22, 1992 |
| Grant date | Jan 9, 1996 |
| Priority date | — |
| Expiry date | Dec 22, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a technique for treating a mammal with rapamycin which comprises removal of blood from the patient, treatment of the formed blood elements with rapamycin which binds rapidly and reversibly with erythrocytes, and returning the treated blood cells to the circulatory system of the patient for the treatment of any of the diseases, syndromes, conditions, or immune responses which respond to treatment with rapamycin. Alternatively, blood to be treated with rapamycin can be obtained from a hematologically compatible donor mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.